000 03946nam a22004095i 4500
001 99946
003 DE-He213
005 20230110040158.0
007 cr nn 008mamaa
008 180105s2018 gw | s |||| 0|eng d
020 _a9783319647692
_9
024 7 _a10.1007/978-3-319-64769-2
_2doi
040 _aES-MaUEC
_bspa
050 4 _aRC280.B5 2018 EB
245 1 0 _aPrecision Molecular Pathology of Bladder Cancer
_cedited by Donna E. Hansel, Seth P. Lerner.
264 1 _aCham, Switzerland
_bSpringer International Publishing
_c2018
300 _a1 recurso en línea (IX, 243 páginas 40 ilustraciones, 38 ilustraciones a color)
336 _2rdacontent
_aTexto
_btxt
337 _2rdamedia
_aelectrónico
_bc
338 _2rdacarrier
_arecurso electrónico
_bcr
347 _atext file
_bPDF
490 0 _aMolecular Pathology Library
_x1935-987X
505 0 _a1.Risk Factors and Molecular Features Associated with Bladder Cancer Development.- 2.Grading, Staging, and Morphologic Risk Stratification of Bladder Cancer --  3.Genomic Assessment of Muscle-Invasive Bladder Cancer: Insights from The Cancer Genome Atlas (TCGA) Project --  4.Molecular Alterations in the Pathogenesis of Bladder Cancer Subtypes and Urothelial Carcinoma Variants -- 5.Treatment Paradigms in Bladder Cancer: Clinical Implications of Histological and Molecular Analysis.- 6.Requisite for Collection and Distribution of Tissue and Fluid Specimens for Molecular Diagnostics and Discovery in Bladder Cancer --  7.Diagnostic, Prognostic and Predictive Biomarkers on Bladder Tissue and Blood -- 8.Urine Cytology and Existing Urinary Biomarkers for Bladder Cancer.- 9.Molecular Targeted Therapy of Bladder Cancer -- 10.Response to Immunotherapy: Application of Molecular Pathology to Predict Successful Response -- 11.Emerging Molecular Approaches in the Analysis of Urine in Bladder Cancer Diagnosis -- 12. Stromal Contributions to Tumor Progression in Urothelial  Carcinoma of the Bladder -- 13.Modeling Bladder Cancer with Genetic Engineering: Fidelity of Human-to-laboratory Models.      .
520 3 _aThis succinct yet comprehensive volume describes current and emerging concepts in molecular pathology of bladder cancer. Divided into two distinct sections, the first part focuses on the general principles of molecular findings in bladder cancer, while the second part focuses on the molecular changes associated with specific histologic subtypes. The volume also addresses such topics as molecular alterations in non-invasive and invasive disease, including bladder cancer variants as appropriate, emerging molecular classifiers of bladder cancer, and molecular associations to outcome and treatment. Written by experts in the field, Precision Molecular Pathology of Bladder Cancer is a valuable resource for those in the urologic community, including urologic pathologists, urologists, urologic oncologists and radiation oncologists, who treat and manage bladder cancer.
650 7 _aVejiga
_xCáncer
_9667082
_2embne
650 7 _aOncología
_2embne
_9139207
700 1 _aHansel, Donna E.
_eeditor literario
_0http://id.loc.gov/authorities/names/n2005183817
_0http://viaf.org/viaf/24017825
_996645
700 1 _aLerner, Seth P.
_eeditor literario
_0http://id.loc.gov/authorities/names/n2006180496
_0http://viaf.org/viaf/166296855
710 2 _aSpringerLink (Online service)
_0http://id.loc.gov/authorities/names/no2005046756
_0http://viaf.org/viaf/148105729
_9106996
776 0 8 _iEdición impresa:
_z9783319647678
776 0 8 _iEdición impresa:
_z9783319647685
776 0 8 _iEdición impresa:
_z9783319878676
856 4 0 _uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://doi.org/10.1007/978-3-319-64769-2
_zAcceso a este recurso digital (usuarios Universidad Europea de Madrid)
490 0 _aMedicine (Springer-11650)
988 _aSpringer_Medicine_2018
998 _b01/2019
_dz
_ef
_feng
_ggw
_h0
999 _c99946
_d99946
_x1